A new Northwestern Medicine study found an experimental drug did not lower hospitalization among patients suffering from heart failure with preserved ejection fraction.
Year: 2019
Joel Voss, PhD, and John Disterhoft, PhD, have received a $6.3 million grant from the NIH as part of the BRAIN Initiative.
Genetic modifier protein Annexin A6 accelerates acute and chronic muscle injury repair by more than 50 percent.
Feinberg celebrates the remarkable achievements of Northwestern’s women faculty in medicine and commemorates their contributions to science, clinical medicine, and society.
A revolutionary new approach that analyzes a tiny sample of blood, can detect life-threatening vascular complications in diabetic patients earlier and more accurately than traditional tests.
Talia Lerner, PhD, has received the NIH Director’s New Innovator Award, an early-career grant supporting projects in the biomedical, behavioral or social sciences.
Feinberg faculty and students celebrated the ninth annual Medical Education Day at the Robert H. Lurie Medical Research Center with sessions, lectures and workshops that examined the future of medical education.
Northwestern has established the new Center for Food Allergy and Asthma Research, which will provide investigators and patients more support while uncovering new discoveries from applied and basic science research on allergies.
The first prostate cancer treatment based on the genetic makeup of the cancer resulted in significant improvements, according to a large international trial led by Northwestern Medicine investigators.
Three Chicagoland high school students created the PeelTowel, a citrus peel-based, anti-microbial paper towel, and tested it in the laboratory of Alan Hauser, MD, PhD, vice chair of the Department of Microbiology-Immunology.